Biggest News Aggregation in the World
๐Ÿ“ฐ From Concept News

Page 4 - From Concept News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from From Concept. Real-time updates on events, politics, business and more.

Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead™ Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium

/PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi...
United States Nigel Yip Dmitry Samarsky Bunny Lee Alexis Feinberg Patrick Lu

Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium

GAITHERSBURG, Md. and SUZHOU, China, June 22, 2022 /PRNewswire/ -- Sirnaomics Ltd.(the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company's Chief Technology Officer, Dmitry Samarsky, PhD, will present the latest developments and expanded applications of its Dual-Targeted RNAi therapeutics based on its proprietary GalAhead technology and product pipeline, at the ...
United States Nigel Yip Dmitry Samarsky Bunny Lee Alexis Feinberg Patrick Lu

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium

GAITHERSBURG, Md. and SUZHOU, China, June 22, 2022 /PRNewswire/ -- Sirnaomics Ltd.(the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company's Chief Technology Officer, Dmitry Samarsky, PhD, will present the latest developments and expanded applications of its Dual-Targeted RNAi therapeutics based on its proprietary GalAhead technology and product pipeline, at the ...
United States Nigel Yip Dmitry Samarsky Bunny Lee Alexis Feinberg Patrick Lu

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science